Veldoreotide
Veldoreotide (Somatoprim) is a selective agonist for somatostatin receptor subtypes 2, 4, and 5. It effectively suppresses growth hormone (GH) secretion from pituitary adenomas, including tumors resistant to octreotide, making it a valuable research tool for studying acromegaly and neuroendocrine tumors in vitro and in vivo.
Product Specifications
Field of Research
Pharmacology & Drug Discovery
Molecular Weight
1123.3
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
